Literature DB >> 12354375

Clinical Manifestations and Management of Conversion Disorders.

James A. Bourgeois1, Celia H. Chang, Donald M. Hilty, Mark E. Servis.   

Abstract

Conversion disorder, the acute onset of sensory or motor loss unexplained by physical findings, has long been reported in the neurologic and psychiatric literature. It was once thought to be largely covariate with the "hysterical" (now referred to as "histrionic") personality, but recent work finds that conversion disorder more often presents in the absence of this personality disorder. Conversion disorder may also be part of a chronic pattern of physical expression of psychologic distress known as somatization disorder. Other psychiatric illnesses (particularly mood and anxiety disorders) are frequently comorbid, and conversion disorder and their treatment may affect the prognosis of conversion disorder symptoms. The neurologist suspecting a case of conversion disorder is advised to complete a thorough neurologic evaluation, and to have a low threshold for psychiatric consultation, which facilitates prompt comanagement that may increase the likelihood of a return to premorbid function.

Entities:  

Year:  2002        PMID: 12354375     DOI: 10.1007/s11940-002-0016-2

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  40 in total

1.  Organic syndromes diagnosed as conversion disorder: identification and frequency in a study of 85 patients.

Authors:  F C Moene; E H Landberg; K A Hoogduin; P Spinhoven; L I Hertzberger; R P Kleyweg; J Weeda
Journal:  J Psychosom Res       Date:  2000-07       Impact factor: 3.006

2.  Somatization Disorder.

Authors:  Donald M. Hilty; James A. Bourgeois; Celia H. Chang; Mark E. Servis
Journal:  Curr Treat Options Neurol       Date:  2001-07       Impact factor: 3.598

3.  The functional anatomy of a hysterical paralysis.

Authors:  J C Marshall; P W Halligan; G R Fink; D T Wade; R S Frackowiak
Journal:  Cognition       Date:  1997-07

Review 4.  Globus hystericus or depressivus?

Authors:  E M Cybulska
Journal:  Hosp Med       Date:  1998-08

5.  Motor conversion disorder. A prospective 2- to 5-year follow-up study.

Authors:  M Binzer; G Kullgren
Journal:  Psychosomatics       Date:  1998 Nov-Dec       Impact factor: 2.386

Review 6.  "Hysteria" in clinical neurology.

Authors:  F M Mai
Journal:  Can J Neurol Sci       Date:  1995-05       Impact factor: 2.104

Review 7.  Treatment efficacy: voice disorders.

Authors:  L O Ramig; K Verdolini
Journal:  J Speech Lang Hear Res       Date:  1998-02       Impact factor: 2.297

Review 8.  Pseudoseizures.

Authors:  E S Bowman
Journal:  Psychiatr Clin North Am       Date:  1998-09

9.  Is Briquet's syndrome a heterogeneous disorder?

Authors:  B Liskow; E Othmer; E C Penick; C DeSouza; W Gabrielli
Journal:  Am J Psychiatry       Date:  1986-05       Impact factor: 18.112

Review 10.  True auditory hallucinations as a conversion symptom.

Authors:  M Nakaya
Journal:  Psychopathology       Date:  1995       Impact factor: 1.944

View more
  4 in total

Review 1.  [Conversion disorders. From neurobiology to treatment].

Authors:  C Schönfeldt-Lecuona; B J Connemann; A Höse; M Spitzer; H Walter
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

2.  Conversion disorder presenting with neurologic and respiratory symptoms.

Authors:  Joshua L Roffman; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

3.  Cognitive Behavioral Therapy (CBT) in Psychogenic Non-Epileptic Seizures (PNES): A Case Report and Literature Review.

Authors:  Saher Hoda Kamil; Mustafa Qureshi; Rikinkumar S Patel
Journal:  Behav Sci (Basel)       Date:  2019-01-29

4.  An integrated neuropsychiatric approach to diagnosis and management of patients with epileptic seizures.

Authors:  Donald M Hilty; James A Bourgeois; Steven G Sugden; Celia H Chang; Mark E Servis; Taoufik M Alsaadi
Journal:  Curr Treat Options Neurol       Date:  2005-09       Impact factor: 3.972

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.